IMPORTANCE Emergency departments (ED) are environments that are at high risk for medical errors. Previous studies suggested that the proportion of medical errors may decrease when more than 1 physician is involved.
M edical errors and adverse events remain a major cause of harm, 1,2 and have been described as the third leading cause of death in the United States. [1] [2] [3] In the Emergency department (ED), physicians are required to evaluate multiple patients at the same time and must make rapid decisions with incomplete information. For these reasons, EDs are high-risk environments for errors and subsequent adverse events, with a reported rate of errors up to 10%. 4, 5 In the ED, the care of a patient is often managed by a sole physician. This contrasts with other clinical settings in which patients may benefit from multiple ward rounds, staff meetings, and handovers. Although previous studies have suggested that handovers in the ED can result in a greater risk of adverse events, 6-8 it has been reported that transitions of care may actually be associated with improved outcomes. This has been seen in critical care settings with nighttime cross-coverage, 9 and in pediatric settings after the implementation of a handoff-improvement program. 10, 11 In a previous pilot study, 4 we reported that the involvement of more than 1 physician in the care of the patient, such as handoff between 2 emergency physicians, was associated with a reduced risk of adverse events and medical error. These findings are also in line with high-risk industry settings, where important actions need to be cross-checked by a peer (the closing of aircraft doors for example). Cross-checking between 2 emergency physicians is an opportunity to discuss their patients, receive feedback from their peers, and share the decision-making process. The purpose of this randomized cluster crossover superiority trial was to test the hypothesis that implementation of systematic cross-checking between 2 emergency physicians would result in a decreased rate of medical errors.
Methods

Study Design
The study methods have been described in detail previously. 12 The CHARMED (cross-checking to reduce adverse events resulting from medical errors in the emergency department) trial was a prospective, cluster randomized, 2-period crossover study in a convenience sample of 6 EDs (6 invited, 0 refused) in France (NCT02356926). Randomization of the order of exposure was performed by an independent statistician. The unit of randomization was the ED. One block of size 6 was used to generate the list. For each number on the list (from 1 to 6), the order of exposure to the intervention was randomly assigned (3 numbers for each order of exposure). Then this randomization list was combined with the blinded list of centers previously numbered.
The trial consisted of 2 periods. Each period lasted 10 days (Monday to Friday for 2 weeks), separated by a 1-month washout period. We chose a cluster crossover design instead of a parallel cluster to limit a "site effect" because we anticipated that the primary end point rate could vary between centers. In the first period, the strategy (intervention or control) was assigned randomly to each center (3 centers intervention, 3 control). After the 1-month washout, the alternative strategy was applied to each center.
The trial was approved by our institutional review board (Comité des Protection de Personnes, Paris île-de-France 6), with a waiver of individual signed informed consent. We followed the CONSORT extension for cluster randomized trial guidelines for the reporting of this study (Figure) . 13 The trial protocol is available in Supplement 1.
Intervention
In our centers, all emergency patients are managed by a substantively employed senior emergency physician (consultant/ attending grade equivalent), with or without a trainee. During weekdays, the number of emergency physicians working in the 6 EDs varies from 4 to 7. During the nights or weekends, 2 to 4 physicians are on call. During the intervention periods, repeated systematic crosschecking between emergency physicians were implemented. Three times a day, between 8:30 AM and 6:00 PM (corresponding to the period of the day-shift), a clinical research technician (CRT) sought all emergency physicians (not including trainees) working in the ED and asked them to meet with a peer (ie, another senior emergency physician) and discuss all his or her current patients. Each physician presented the patients he or she was actually taking care of with a brief description of the medical case. The physicians were not previously trained, and the sessions were standardized, with a written copy of the plan of cross-checking handed by the CRT to the physicians, including the following items 9 : sex, age, chief complaint and main medical history; main clinical findings; main investigation available or outstanding; treatment given in the ED; and a brief summary of the plan. After presenting each of their patients, the emergency physician sought feedback and comments from his or her peer. In cases where a peer was not available (eg, when there were uneven numbers of emergency physicians present at the time of cross-checking) a trainee was chosen to be the cross-checker. The CRT witnessed the procedure and recorded the number and names of the cross-checked patients, the duration of the procedure, and whether the cross-checker peer was a trainee or not.
Study Population
would not have been exposed to the intervention; patients whose care was not provided by an emergency physician (eg, patients with issues pertaining to mental health); scheduled return visits to the ED; and low-acuity patients. This latter group was excluded because their anticipated short length of stay in the ED meant that it would have been unlikely that they would be exposed to the intervention. These were patients referred to the "fast track" or "minor" unit, patients with a triage level 5ona1to5scale(5being the lowest acuity) or patients discharged home less than 1 hour after first contact with the emergency physician.
14 A triage category is assigned to all patients during their initial encounter with a triage nurse. We needed to include 140 patients in each center for each period (total of 1680). After the completion of each period, we listed all eligible patients for each day through the electronic medical record software (Urqual McKesson). Data were extracted by a third party on the shared electronic database and then randomly ordered using a computer-generated random list (alea function of Microsoft Excel; Microsoft). We then selected the first 14 patients for each of the 10 days in each center for analysis. If a patient could not be analyzed because he or she did not meet the inclusion criteria, we included the next eligible patient on the list of the day.
Study Outcomes
The primary end point was the rate of patients with an adverse event (preventable or not), defined as a near miss (a medical error that has the potential to cause an adverse event, but did not, either by chance or after an intervention) or a serious adverse event (preventable or not, an injury that might have resulted from medical care or lack thereof).
Before the start of the study, we slightly modified our primary end point that was initially "near miss or serious adverse event" to "near miss or preventable serious adverse event," because we considered that nonpreventable adverse events could not be defined as a medical error. Unfortunately, the registry (NCT02356926) was not updated subsequently. However the methods overview, published before the start of the study, incorporated this change. For the purpose of transparency, we provide here the result for our initial registry-specified primary end point, and also provide additional results for the modified protocol-specified end point that was mentioned in the method paper.
Secondary end points included the rate of near miss, the rate of serious adverse events, and the rate of preventable serious adverse events. To detect adverse events resulting from medical error that did not occur during the ED stay, any return visit to the ED or new hospital admission in the same institution was sought in the 7 days after the index visit to detect any adverse event subsequent to the ED visit. We used a 2-level review standard methodology to detect medical errors.
5,10,11,15 First, the local investigator, who was an emergency physician, screened all selected charts from his or her center to detect any situation at risk of an adverse event or a near miss (eFigure in Supplement 2). These situations were identified using a questionnaire derived from the National Emergency Department Safety Study. 12,15 All medical records with at least 1 positive item in the questionnaire then underwent blinded assessment by 2 independent experts who were trained in detecting error. The analysis was blinded to the strategy allocation and names of the physicians involved in the patients' management. In cases of disagreement between the 2 experts (80% agreement; Cohen κ = 0.35; 95% CI, 0.27-0.43), the pair of experts sought reconciliation by discussion. If they could not agree, a tie-breaker third expert was obtained (n = 15 cases [2%]). In the case where several adverse events or near misses were observed in the same patient, the most severe preventable adverse event or near miss was considered. The experts subsequently adjudicated the preventability of the serious adverse event, and whether it was owing to an emergency physician or to another physician. Then the expert pair classified any medical error according to its severity using the National Coordinating Council on Medication Error and Reporting, 16 a categorization system designed for medication errors, running from B (an error that did not reach the patient) to I (an error that may have contributed to the death of the patient). To assess whether the first level of reviewing did not miss a significant proportion of medical error, 102 patient medical records were randomly selected (17 in each center), among those that were not screened positive in the first level, and sent to the second level assessment, which was not blinded to the result of the first screening. We defined the first level review reliable if fewer than 2% of patients were found to meet the primary end point. Eventually, only 1 medical record was adjudicated with a near miss (1%; 95% CI, 0%-5%). 
Results
A total of 1680 patients (n = 840 in each group) were included. Main characteristics of patients were similar in the 2 groups ( Table 1) . Characteristics of the recruiting centers are reported in eTables 1 and 2 in Supplement 2. In the first level of medical record review, a total of 818 cases (49%) were identified as being at risk of a medical error and were subjected to the second level review by a pair of experts. Of these, 151 adverse events or near misses were identified in 144 patients (18%), including 9 (1%) nonpreventable adverse events.
Medical Errors, Near Misses, and Adverse Events Table 2 ).
The analysis of the 69 serious adverse events showed that the management of patients considered septic was prone to error, with 24 adverse events (34%) that were related to a lack of recognition or adequate resuscitation and antibiotic therapy in patients with infections (Table 3) . Among the 60 preventable serious adverse events, 4 (7%) occurred after the care of a physician other than an emergency physician (eg, orthopedist or intensivist).
Cross-checking
The CRTs recorded 382 cross-checking sessions during the intervention period in the 6 centers, which identified 573 patients (68%) that were cross-checked during the intervention period (median [range], 63% [44%-100%] between the different centers). In 7 cases (2%), physicians could not or refused to attend the session. The median [IQR] duration of the sessions was 9 [5-13] minutes, and a median (IQR) number of 7 (4-9) patients were cross-checked during each session. In 60 cases (16%), the cross-checker was a trainee.
The sequence order of the periods was not associated with a higher risk of medical error, and there was no significant period effect (eTable 4 in Supplement 2). Finally, the additional analyses using Fisher exact test and the Cochran-MantelHaenszel test confirmed our results with a risk ratio for the primary end point of 0.57 and 0.61 respectively for each test. Finally, sensitivity analyses using logistic random effect model showed similar results to those obtained with the initial model (preventable adverse events or near misses: RRR = 42%, 95% CI, 17%-60%; P = .003 and adverse events or near misses: RRR = 43%, 95% CI, 19%-60%; P = .002).
Since the cross-checking procedure occurred 3 times per day in the intervention group, some patients may have been treated outside these hours (seen and discharged between 2 cross-checking sessions for example). Indeed, 267 patients (32%) in the intervention groups did not actually receive a cross-checking. The per-protocol analysis found no significant reduction in the rate of medical error for patients that were actually cross-checked (n = 573) vs others (n = 1107), with a RRR of 19% (95% CI, −16% to 43%). However, as presentedineTable3inSupplement 2, patients that were crosschecked were older, stayed longer in the ED, and had a more severe presentation.
Discussion
In this multicenter randomized cluster crossover study, the implementation of systematic cross-checking between emergency physicians was associated with a 40% relative reduction in the rate of adverse events, mostly by reducing the rate of near miss.
We used an active 2-level surveillance system derived from that described in other studies on medical errors.
2,18,19
The observed medical error rate of 10% in the ED, was similar to that reported in the NEDSS study and in our pilot study.
4,5
A less active process of screening for medical errors often resulted in a lower rate of medical errors in the ED, and may be seen as too optimistic. [20] [21] [22] [23] [24] The surveillance system for error detection seemed reliable. It sampled 818 of 1680 patients (49%) with a high incidence of medical error (135 of 818 [17%]), and subsequently underwent comprehensive review by a pair of experts, blinded to each other. On the other hand, the remaining half patients that did not undergo a second review seemed to have a very-low rate (1%) of medical error.
The 40% reduction rate in adverse events that is observed is in line with other studies in different settings that assessed the benefit of transition of care and simple interventions aimed at improving its quality.
9-11 The implementation of a handoff bundle was associated with a 30% reduction in the rate of adverse events in a pediatric ward. 10, 11 In the ED, such interventions would only expose a small fraction of patients because most of them are seen and discharged or admitted outside of the time designated for handoff. 4 Systematic cross-checking allows that a higher fraction of patients benefit from the opinion of a second physician. The implementation of checklists was also reported to reduce the rate of medical error. [25] [26] [27] However, due to the broad variety of pathology and patients in the ED, it seems difficult to transpose this intervention into the ED setting.
Owing to the retrospective nature of our event analysis, it was difficult to determine the exact nature of the error that led to an adverse event. Whether an adverse event resulted from a misdiagnosis or from the implementation of an inappropriate plan for the correct diagnosis could not be determined decisively. This included sepsis-associated medical errors, which may be particularly relevant, because the most commonly occurring serious adverse events were violations of the surviving sepsis campaign guidelines.
28 This is particularly interesting as a recent study 29 reported similar results on patients with a short-term unexpected death after an ED visit. Leisman et al 30 also recently highlighted the importance of compliance with the sepsis guidelines, with the report of an independent association between mortality and deviation from a sepsis bundle. It is likely that systematic cross-checking reduced the rate of adverse events errors by allowing a reevaluation of the patient by the peer cross-checker, who is able to cast a fresh eye on the patient's management. Moreover, the cross-checks may have forced the physician to reconsider his or her initial diagnosis and management plan and, in turn, intercept an error. The involvement of a second physician in the process of care may help intercepting adverse events and near misses, hence the reduction that we observed in our study.
4,9,31
In a per-protocol analysis, we found no significant reduction in the rate of adverse event for patients that were actually cross-checked (n = 573) vs others (n = 1107). This does not contradict our results because the 2 populations were not similar (eTable 3 in Supplement 2): cross-checked patients were sicker than per-protocol standard patients; therefore, confounding factors may have limited the effect of the crosschecking. Moreover, the study was not powered to detect a difference between these 2 groups.
Limitations
Our study has some limitations. We were unable to determine decisively that the observed benefit was the result of the intervention. We did not account for potential undocumented cross-checking that might have occurred spontaneously between physicians. However we believe that this did not happen often in the control group because this was a novel intervention. The risk of contamination in the second period for centers that were assigned to start with the intervention is limited because the first period was short (10 days) and was followed by a wash-out period. It is possible that some cross-checking occurred in the control group. However, the absence of period effect and sequence order effect advocates for the impact of the intervention. We could not control all confounding variables, for instance the presence of the CRT, which may have led to extra caution during the cross-checking period. Because we did not collect the name of the emergency physicians working in the ED during the study period, it is possible that different physicians staffed the ED in the 2 periods. This could also have created a bias as different physicians may present different risks of medical errors. Furthermore, the wide confidence intervals we provide for our primary end point is compatible with a smaller difference than anticipated.
As we sought for 7 days reattendance in the same hospital, we may have missed some serious adverse events that precipitated a patient having a return visit to another hospital. The observed agreement (κ = 0.35) for the adjudication of the primary end point could be seen as a limitation but is nonetheless considered to be fair agreement. 32 Furthermore, it is close to that observed in the study by Starmer et al, 10 which used the same active surveillance process (κ = 0.44), as well as in the study by Camargo et al (κ = 0.34). 5 In addition, in cases of disagreement between the 2 experts, a consensus was found in 91% of the cases. Another limitation of our study lies in its lack of generalizability, as we only included a convenience sample of 6 EDs, and 5 centers of 6 were in an urban academic hospital in the Paris metropolitan area. Furthermore, the fact that a CRT was present in the ED during the intervention period may have facilitated physician's adherence to the cross-checks, and further studies are needed to assess the feasibility of this protocol in busy EDs. Finally, our study was underpowered to identify a significant effect on the rate of preventable adverse events, nor was it powered to identify a significant site-level effect.
Conclusions
In this multicenter cluster crossover superiority trial, we report that the implementation of systematic cross-checking between emergency physicians was associated with a significant reduction in adverse events, mostly driven by the reduction of near misses. Since the Institute of Medicine published in 1999 "To err is human", medical errors have been a 116 topic of serious concern. In the United States, medical errors could be responsible of 100 000 117 deaths per year and more than one million injuries. In France, 10 000 deaths and up to 3% of all 118 hospitalizations could be related to medical error. For more than a decade, the rate of harm 119 caused by medical errors has failed to decline although more than a third of them could have 120 been avoided. Cross checking, a fast procedure, easy to implement even in an overcrowded ED, has been 166 widely adopted in high-risk industries, such as aviation setting, to ensure the highest levels of 167 safety. Thus, this study will also report the feasibility of the implementation of systematic Cross 168
Checking in the ED. The number and diversity of participating centers in France will be a solid 169 argument for future generalization if our hypothesis is confirmed 170
171
The settings of ED practice generally include that the care of the patients is left to the decision 172 and action of a sole physician. The results of our preliminary study suggest that exchange of 173 information and shared management are beneficial to the patient and reduce the rate of 174 adverse event. If our hypothesis is demonstrated, the implementation of a systematic and 175 frequent crosschecking of ED physician with each other will help to reduce considerably the 176 morbidity and mortality from medical errors in the ED. 177
2.3
Potential recruitment Serious guidelines violation (local or national), even in the absence of any documented injury, 195 will be considered as adverse events. As previously described, the subsequent adverse events 196 might not clearly appear in the ED settings, hence is considered as a SME 197 As we are evaluating the influence of Cross-Checking, that will occur every two hours, we will 223 exclude all patients whose medical management will be less than one hour in the ED. Duration 224 of medical management will be equal to the delay between first medical contact and discharge 225 time. In both periods, from 9am to 5pm, a CRT will be present in the ED to collect variables on 248 providers and patients. 249
In the control period, usual care and routine management will be provided. 250
In the intervention group, systematic cross-checking will be implemented three times a day 251 from 8:30am to 6:00pm between emergency physicians. 252
253
At the end of each period, 14 patients' chart per day in each center will be randomly selected for 254 review. We will use a two-level reviewing method as previously detailed. In the control period, usual care and routine management will be provided. 261
262
In the intervention group, systematic cross-checking will be implemented three times a day 263 from 8:30am to 6:00pm between emergency physicians. The CRT will seek emergency 264 physicians (EP) by pairs for crosschecking. Senior physicians will use peer crosschecking (i.e. 265 crosschecker will also be an emergency senior physician). The CRT will assist the pairing. Each 266 EP will prepare to present all his or her current patients. Patient presentation will be 267 protocolised, although usual presentation will be sought as this is the presentation method 268 already in place for handover. The crosschecking will occur in the presence of the CRT and in 269 the ED, in any medical office staff room, or cubicle available. The recommended duration of the 270 cross-checkings will be 5 to 10 min. 271
After each presentation, the comments and advice of the crosschecker will be sought. The CRT 272 will collect duration of the sessions, with the initial and date of birth of any crosschecked 273 patients. 274
Chart selection
276
The participating centers used an electronic system that collect every ED visits, including 277 severity triage level, time of first contact with physician, time and discharge disposition. 278
A CRT will select all visits that fulfill the inclusion criteria on an electronic file that will include 279 name, date of brith and time of ED visit. Each patients will be linked to a identifier number J n -280 000X, n between 1 and 20 corresponding to the day of the visit.. The file with correspondence 281 between name and number will be kept in the local institution in the investigator folder. 282
The research and methodology department will then randomly select 14 patients each day for 283
analysis. 284
The randomization list will then be sent to the center, and a CRT will retrieve the complete 285 medical chart pertaining to the ED visit, and if any the discharge summaries of hospital stay. 286
Any new attendance in the ED within the next seven days will be sought. After all charts have 287 been blinded to any mention of date, period and group, Severe Medical Errors will be assessed 288 using a validated two-level reviewing, as express in figure 2. Before the start of the study, all local investigator will be train to chart abstraction for the first 295 level reviewing from the primary investigator. These courses will be held either by 296 teleconference, or direct interview, with the presentation of a syllabi and ghost charts for 297
training. This training has been used in previous study. For all selected patients, a CRT will retrieve the complete medical chart pertaining to the ED 303 visit, and if the patient was admitted into hospital, discharge summaries following hospital 304 discharge. Repeat attendance in the ED within the next seven days will be recorded. All charts 305 will be blinded to date, period and group. Chart review for SME will then be assessed in a 306 validated two phase review process ( figure 2) . 307
This first chart review phase will use a an adapted validated questionnaire, derived from the 308 NEDSS study, as a screen to detect adverse events and near misses. Any chart that screens positive for at least one item at the first review phase will be sent for 313 external validation and confirmation in the second review phase. These screen-positive charts 314 will be centralized at the methodology and research department and will be independently 315 reviewed by two physicians from a review expert panel in the second chart review phase. This 316 panel will include board-certified emergency physicians and experts in patient safety. Some of 317 the panel members are already trained to chart abstraction and errors validation and 318 classification. The others from the panel will complete a specific training session, with practice 319 chart review and presentation of classification of error in their severity (according to 320 NCCMERP). In cases of disagreement after discussion with the paired reviewer and failure to 321 reach consensus, a third expert, faculty member emergency physician, will be sought to make a 322 final decision. The preventability of any potential adverse event will be reported on a Likert scale 323 as follows: 0) highly unlikely 1) unlikely 2) likely 3) highly likely. 324
Mean to limit bias
326
A. Reliability of the first level 327
To evaluate whether the first level is reliable, we will randomly select 100 charts that were 328 initially screened negative on the first level, and send them for external reviewing. If the rate of 329 SME is higher than 2% (i.e. upper 95% confidence interval (CI) bound > 5%), all charts will 330 undergo the second level of reviewing to limit selection bias. 331 332 B. Justification of the choice of a cluster cross-over design 333
334
Given the type of intervention in the ED, it is mandatory that it is implemented for a least a 335 whole day in the same center. An individual patient randomisation is unrealistic in this case. We 336 chose to use a cross-over design as a "before-after" design would be subject to bias, especially 337 period effect, as mentioned by L Horwitz about the firs Starmer study on protocolised handoff. 24 
338
With a short implementation period (10 days) and a one month wash out, we may limit the risk 339 of contamination for the centers that will be randomized as strating with the cross-checkings 340 These data will be entered in the e-CRF by a CRT, using the printed medicla charts used for the 348 first level reviewing. 349
The data regarding the second level reviewing (adjudication of primary and secondary 350 endpoints) will be noted by the experts on a paper CRF, then later recorderd in the e-CRF by a 351
CRT. 352
Data management will be held by a data manager from URC-Est. We plan no interim analysis. 358
Patients' characteristics will be described in each group according to the strategy (cross-359 checkings and control). Characteristics of each center will also be described, as characteristics 360 of the cross-checkings session. 361
Qualitative data will be reported as number and percentage, and quantitative data as mean and 362 standard deviation or median and interquartile range. 363
364
Analysis of the primary endpoint:
The effect of cross-checking will be estimated through a generalized estimating equation (GEE) 367 model, which will take into account the independence of intracluster observations. Factors 368 associated with SME will also be sought with a GEE Model. Rate of adverse event and near 369 miss will be described and compared between the two periods with a chi square test 
STEERING COMITTEE
390
The steering comittee will comprises YF, HG, BR -who conceived the study, the biostatistician 391 (AR) of the methodology department and the coordinator of the methodology (TS) 392
Access to data
393
In accordance with GCPs: 394 -the sponsor is responsible for obtaining the permission of all parties involved in the research to 395 guarantee direct access to all locations where the research will be carried out, to the source 396 data, to the source documents and the reports, with the goal of quality control and audit by the 397 sponsor 398 -the investigators will make available to those in charge of monitoring, quality control and audit 399 relating to the biomedical research the documents and personal data strictly necessary for 400 these controls, in accordance with the legislative and regulatory provisions in force (Articles Each investigator will undertake to comply with the legislation and to carry out the research 540 according to French GCP, adhering to the Declaration of Helsinki terms in force. 541
The primary investigator at each participating centre will sign a responsibility commitment 542 (standard DRCD document) which will be sent to the sponsor's representative. 543
The investigators and their employees will sign a delegation of duties form specifying each 544 
